Evidence map›Paper›PMID 29132314›Full record

ArticleBMC genomics2017

Proteomics in non-human primates: utilizing RNA-Seq data to improve protein identification by mass spectrometry in vervet monkeys.

J Michael Proffitt, Jeremy Glenn, Anthony J Cesnik, Avinash Jadhav, Michael R Shortreed, Lloyd M Smith, Kylie Kavanagh, Laura A Cox, Michael Olivier

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Identification of Novel Genes and Proteoforms inPathogens (Basel, Switzerland) · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Prime time for primate functional genomics.Current opinion in genetics & development · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

J Michael ProffittDepartment of Genetics, Texas Biomedical Research Institute, San Antonio, Texas, USA.
Jeremy GlennDepartment of Genetics, Texas Biomedical Research Institute, San Antonio, Texas, USA.
Anthony J CesnikDepartment of Chemistry, University of Wisconsin, Madison, Wisconsin, USA.
Avinash JadhavDepartment of Genetics, Texas Biomedical Research Institute, San Antonio, Texas, USA.
Michael R ShortreedDepartment of Chemistry, University of Wisconsin, Madison, Wisconsin, USA.
Lloyd M SmithDepartment of Chemistry, University of Wisconsin, Madison, Wisconsin, USA.
Kylie KavanaghDepartment of Pathology and Comparative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Laura A CoxDepartment of Genetics, Texas Biomedical Research Institute, San Antonio, Texas, USA.
Michael OlivierDepartment of Genetics, Texas Biomedical Research Institute, San Antonio, Texas, USA. molivier@wakehealth.edu.
Texas Biomedical Research Institute · USWake Forest University · USUniversity of Wisconsin–Madison · USEnergy Center of Wisconsin · US

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
Research Training for Computation and Informatics in Biology and MedicineT15LM007359 · NLM · UNIVERSITY OF WISCONSIN-MADISON · PI Mark W. Craven, Colin Noel Dewey · 2002 to 2026
$22.6M
PARTURITION AND FETAL PRIMATE HYPOTHALAMIC FUNCTIONP01HD021350 · NICHD · UNIVERSITY OF WYOMING · PI NATHANIELSZ, PETER W. · 1987 to 2018
$19.9M
Vervet Research Colony as a Biomedical ResourceP40OD010965 · OD · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Matthew Jorgensen · 2012 to 2026
$14.6M
EXTRAMULAR RESEARCH FACILITIES CONSTRUCTIONC06RR017515 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI SHADE, ROBERT E · 2003 to 2003
$3.1M
Functional characterization of regulatory sequence variants in complex diseasesR01GM109099 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI OLIVIER, MICHAEL · 2014 to 2017
$2.6M
MOLECULAR AND BIOCHEMICAL GENETICS LABORATORY RENOVATIONC06RR013556 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI SHADE, ROBERT E · 1998 to 1998
–
National Center for Advancing Translational Sciences UL1 TR004120National Center for Research Resources 1 C06 RR013556National Center for Research Resources 1 C06 RR017515National Institute of General Medical Sciences R01 GM109099NCRR NIH HHS C06 RR013556NCRR NIH HHS C06 RR017515NICHD NIH HHS P01 HD021350NIGMS NIH HHS R01 GM109099NIH HHS P40 OD010965NIH HHS P51 OD011133NIH Office of the Director P40 OD010965NIH Office of the Director P51 OD011133NLM NIH HHS T15 LM007359U.S. National Library of Medicine T15LM007359
6 · The paper itself

Abstract

backgroundShotgun proteomics utilizes a database search strategy to compare detected mass spectra to a library of theoretical spectra derived from reference genome information. As such, the robustness of proteomics results is contingent upon the completeness and accuracy of the gene annotation in the reference genome. For animal models of disease where genomic annotation is incomplete, such as non-human primates, proteogenomic methods can improve the detection of proteins by incorporating transcriptional data from RNA-Seq to improve proteomics search databases used for peptide spectral matching. Customized search databases derived from RNA-Seq data are capable of identifying unannotated genetic and splice variants while simultaneously reducing the number of comparisons to only those transcripts actively expressed in the tissue.

resultsWe collected RNA-Seq and proteomic data from 10 vervet monkey liver samples and used the RNA-Seq data to curate sample-specific search databases which were analyzed in the program Morpheus. We compared these results against those from a search database generated from the reference vervet genome. A total of 284 previously unannotated splice junctions were predicted by the RNA-Seq data, 92 of which were confirmed by peptide spectral matches. More than half (53/92) of these unannotated splice variants had orthologs in other non-human primates, suggesting that failure to match these peptides in the reference analyses likely arose from incomplete gene model information. The sample-specific databases also identified 101 unique peptides containing single amino acid substitutions which were missed by the reference database. Because the sample-specific searches were restricted to actively expressed transcripts, the search databases were smaller, more computationally efficient, and identified more peptides at the empirically derived 1 % false discovery rate.

conclusionProteogenomic approaches are ideally suited to facilitate the discovery and annotation of proteins in less widely studies animal models such as non-human primates. We expect that these approaches will help to improve existing genome annotations of non-human primate species such as vervet.

Indexed as

Mass SpectrometrySequence Analysis, RNAAnimalsChlorocebus aethiopsDatabases, GeneticMolecular Sequence AnnotationProteomicsReference StandardsGalaxy-PLiverMorpheusNon-human primateProteogenomicsProteomicsRNA-SeqVervet

Identifiers

PMID29132314
PMCPMC5683380
OpenAlexW2768306313

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.